The National Institute for Occupational Safety and Health (NIOSH) Alert: Preventing Occupational Exposures to Antineoplastic and Other Hazardous Drugs in Health Care Settings. http://www.cdc.gov/niosh/docs/2004-165/pdfs/2004-165.pdf (2017年5月31日アクセス)
NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2016. https://www.cdc.gov/niosh/docs/2016-161/default.html (2017年5月31日アクセス)
Connor TH, Lawson CC, Polovich M, et al: Reproductive health risks associated with occupational exposures to antineoplastic drugs in health care settings: a review of the evidence. J Occup Environ Med 56(9): 901-910,2014.
Ries LAG, Harkins D, Krapcho M, et al: SEER Cancer Statistics Review, 1975-2003, National Cancer Institute. Bethesda, 2006. http://seer.cancer.gov/csr/1975_2003/ (based on November 2005 SEER data submission, posted to the SEER web site)
International Agency for Research on Cancer: Agents Classified by the IARC Monographs, Volumes 1-118. http://monographs.iarc.fr/ENG/Classification/(2017年5月31日アクセス)